5uqy
From Proteopedia
(Difference between revisions)
(New page: ==Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78== <StructureSection load='5uqy' size='340' side='right' caption='5uqy, [[Resolution|resolution...) |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78== | ==Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78== | ||
- | <StructureSection load='5uqy' size='340' side='right' caption='[[5uqy]], [[Resolution|resolution]] 3.60Å' scene=''> | + | <StructureSection load='5uqy' size='340' side='right'caption='[[5uqy]], [[Resolution|resolution]] 3.60Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5uqy]] is a 16 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5uqy]] is a 16 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Ravn_virus_-_Ravn,_Kenya,_1987 Ravn virus - Ravn, Kenya, 1987]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=3x2d 3x2d]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5UQY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5UQY FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.6Å</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5uqy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5uqy OCA], [https://pdbe.org/5uqy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5uqy RCSB], [https://www.ebi.ac.uk/pdbsum/5uqy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5uqy ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/VGP_MABVR VGP_MABVR] GP1 is responsible for binding to the receptor(s) on target cells. Interacts with CD209/DC-SIGN and CLEC4M/DC-SIGNR which act as cofactors for virus entry into the host cell. Binding to CD209 and CLEC4M, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses, facilitate infection of macrophages and endothelial cells. These interactions not only facilitate virus cell entry, but also allow capture of viral particles by DCs and subsequent transmission to susceptible cells without DCs infection (trans infection) (By similarity). GP2 acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane. Low pH in endosomes induces an irreversible conformational change in GP2, releasing the fusion hydrophobic peptide (By similarity). |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 18: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5uqy" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5uqy" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Glycoprotein GP 3D structures|Glycoprotein GP 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Line 23: | Line 27: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Crowe | + | [[Category: Ravn virus - Ravn, Kenya, 1987]] |
- | [[Category: Flyak | + | [[Category: Bomholdt ZA]] |
- | [[Category: Fusco | + | [[Category: Crowe JE]] |
- | [[Category: Hammel | + | [[Category: Flyak AI]] |
- | [[Category: Hashiguchi | + | [[Category: Fusco ML]] |
- | [[Category: Hastie | + | [[Category: Hammel M]] |
- | [[Category: Kohda | + | [[Category: Hashiguchi T]] |
- | [[Category: Lee | + | [[Category: Hastie KM]] |
- | [[Category: Matsuoka | + | [[Category: Kohda D]] |
- | [[Category: Saphire | + | [[Category: Lee JE]] |
- | [[Category: Yanagi | + | [[Category: Matsuoka R]] |
- | + | [[Category: Saphire EO]] | |
- | + | [[Category: Yanagi Y]] | |
- | + | ||
- | + | ||
- | + |
Current revision
Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78
|
Categories: Homo sapiens | Large Structures | Ravn virus - Ravn, Kenya, 1987 | Bomholdt ZA | Crowe JE | Flyak AI | Fusco ML | Hammel M | Hashiguchi T | Hastie KM | Kohda D | Lee JE | Matsuoka R | Saphire EO | Yanagi Y